Clinical Trials · NCT04125836
A Trial to Assess the Long-term Safety of Octreotide Subcutaneous Depot in Patients With Acromegaly
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Camurus AB
- Enrollment
- 135
- Start date
- Oct 2019
- Locations
- 68 sites, 11 countries
- Primary endpoint
- Characterization of adverse events (AEs)